The Geisel School of Medicine at Dartmouth is the graduate medical school of Dartmouth College in Hanover, New Hampshire. The fourth oldest medical school in the United States, it was founded in 1797 by New England physician Nathan Smith. It is one of seven Ivy League medical schools.

During the past decade, Dartmouth Medical School conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 7 clinical trials were completed, i.e. on average, 233.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dartmouth Medical School" #1 sponsor was "Dartmouth-Hitchcock Medical Center" with 5 trials, followed by "Gilead Sciences" with 2 trials sponsored, "University of Alabama at Birmingham" with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "Fred Lublin" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dartmouth Medical School" #1 collaborator was "Dartmouth-Hitchcock Medical Center" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "Arcadia University" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Dartmouth Medical School" are "Alcoholism" (2 trials), "Herpes Simplex Virus" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Relapsing Remitting Multiple Sclerosis" (2 trials) and "Adolescent Substance Use" (1 trials). Many other conditions were trialed in "Dartmouth Medical School" in a lesser frequency.

Most popular intervention types in "Dartmouth Medical School" are "Drug" (9 trials), "Behavioral" (5 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ambrisentan" (2 trials), "BBCET" (1 trials), "BPT" (1 trials) and "CM" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dartmouth Medical School" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Dartmouth Medical School". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Dartmouth Medical School, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dartmouth Medical School, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".